These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13900788)

  • 1. [methylhydroxyethylamino]-2-hydroxypropyltheophylline nicotinate)].
    GOTTSTEIN U; BERNSMEIER A; STEINER K
    Klin Wochenschr; 1962 Aug; 40():772-8. PubMed ID: 13900788
    [No Abstract]   [Full Text] [Related]  

  • 2. [3-(METHYLHYDROXYETHYLAMINO)-2-HYDROXYPROPYLTHEOPHYLLINE NICOTINATE IN THE TREATMENT OF PERIPHERAL ARTERIOPATHIES].
    MAZZEO F; SPAMPINATO N; CORSALE C
    Rass Int Clin Ter; 1964 Sep; 44():947-62. PubMed ID: 14206646
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the changes in the cerebral blood volume under the influence of 3-(methylhydroxyethylamino)-2-hydroxypropyl-theophylline nicotinate with the aid of cranial rheography].
    SCHREIBER H
    Med Klin; 1960 Mar; 55():509-11. PubMed ID: 14443546
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC; Fumagalli G; Locatelli R
    Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
    [No Abstract]   [Full Text] [Related]  

  • 5. [2-hydroxy-3-(N-2-hydroxyethyl-N-methylamino)-propyl]-1,3-dimethylxanthine nicotinate].
    LENNARTZ H
    Arzneimittelforschung; 1962 Jul; 12():675-9. PubMed ID: 14463992
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of acute cerebrovascular disorders by the nicotinic acid ester of 7-(2-hydroxyethyl)-theophylline (hesotin)].
    BARTOUSEK V; CERNY J; DUBANSKY B
    Ther Umsch; 1960 May; 17():182-5. PubMed ID: 13797315
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activation of fibrinolysis with Complamin].
    FISCHBACHER W
    Ther Umsch; 1961 Nov; 18():452-9. PubMed ID: 13893098
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the treatment of dermatological disease pictures with Complamin].
    KLEINHANS H
    Med Klin; 1962 Feb; 57():239-40. PubMed ID: 14456820
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the effects of drugs on the cerebral vessels].
    GLONING K; KLAUSBERGER EM
    Wien Klin Wochenschr; 1959 Nov; 71():880-3. PubMed ID: 13828490
    [No Abstract]   [Full Text] [Related]  

  • 10. [he nicotinic acid of diethylaminoethyltheophylline].
    QUEVAUVILLER A; MORIN H
    Therapie; 1956; 11(4):725-9. PubMed ID: 13352304
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tablets of 7-(3'-(methylhydroxyethylamino)-2'-hydroxypropyl)-theophylline nicotinate with delayed action. I. Moderation of the release of the active substance by some additives].
    Pawlak E; Chodkowska-Granicka B; Surowiecki J
    Acta Pol Pharm; 1971; 28(1):43-7. PubMed ID: 5577811
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the treatment of cerebral sclerosis with complamine].
    KESSENS L
    Med Welt; 1960 Nov; 47():2517-8. PubMed ID: 13752735
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of long-term therapy with Complamin].
    EHRENBERG H
    Hippokrates; 1961 Dec; 32():937-40. PubMed ID: 13889493
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of the treatment of peripheral circulation disorders with Complamine].
    SPERLING M
    Munch Med Wochenschr; 1962 Jul; 104():1273-8. PubMed ID: 13915730
    [No Abstract]   [Full Text] [Related]  

  • 15. [On changes in the cerebrospinal fluid in vaso-active treatment].
    HABECK D; KRISCHEK J
    Med Welt; 1962 Apr; 17():979-82. PubMed ID: 13903374
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on the action of Complamin on systemic circulation and the peripheral skin circulation].
    HEIM E; STORCK H
    Ther Umsch; 1961 Nov; 18():447-51. PubMed ID: 13906019
    [No Abstract]   [Full Text] [Related]  

  • 17. [COMPARATIVE ANALYSIS OF THE VASCULAR EFFECTS OF 3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL-THEOPHYLLINE NICOTINATE, NICOTINIC ACID AND THEOPHYLLINE].
    DEGREGORIO G; BUDA A; FIDECARO A
    Riforma Med; 1964 Aug; 78():937-41. PubMed ID: 14222308
    [No Abstract]   [Full Text] [Related]  

  • 18. [PARENTERAL EFFICACY OF HIGH-DOSED ADENOSINE-THEOPHYLLINE ADMINISTRATION COMBINED WITH NICOTINATE].
    LEDERBOGEN K; BOCKELMANN R; SOMMER H
    Therapiewoche; 1965 Mar; 15():255. PubMed ID: 14305825
    [No Abstract]   [Full Text] [Related]  

  • 19. [2-hydroxy-3-(N-2-hydroxyethyl-N-methylamino)-propyl]-1,3-dim-exthylxanthinenicotinate on cerebrospinal fluid pressure and cerebral circulation].
    HEMMER R; DIEZEMANN E
    Arzneimittelforschung; 1962 Jul; 12():672-5. PubMed ID: 13906366
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON THE TREATMENT OF APOPLEXY WITH COMPLAMIN (7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE].
    FRUHMANN H
    Med Welt; 1963 Oct; 41():2084-7. PubMed ID: 14134155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.